Co-beneldopa (Benserazide/levodopa) Prescribing at THE MAPLES
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
62
Total Quantity
7,500
NHS Cost
£414
vs National Avg
-59%
THE MAPLES prescribed 62 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £414 to the NHS. This is 59% below the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jun 2026
6
Jun 2026
4
Jun 2026
6
Jun 2026
3
Jun 2026
6
Jun 2026
7
Jun 2026
5
Jun 2026
6
Jun 2026
6
Jun 2026
5
Jun 2026
4
Jun 2026
4
Prescribing Details
| Total Items | 62 |
|---|---|
| Total Quantity | 7,500 |
| Total NHS Cost | £414 |
| Presentations | 4 different forms |
| vs National Average | -59% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 62 items |
|---|---|
| National average per practice | 151 items |
| Difference | -59% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.